In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

World’s leading heart failure congress receives record abstract submissions

Heart Failure 2015 is the event of the year in the field

Sophia Antipolis, 23 April 2015: A record number of abstracts have been submitted to the world’s leading heart failure congress, promising more original science than ever before.

Heart Failure

Heart Failure 2015 is the main annual meeting of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) and will be held 23 to 26 May in Seville, Spain, at the Sevilla Palacio de Congresos. The full scientific programme is available here

Professor Frank Ruschitzka, scientific chairperson of the congress and HFA president elect, said: “Heart Failure is considered by the worldwide scientific community as the meeting to attend in the field. We have the most original science and the greatest number of attendees, with nearly 1 600 abstracts submitted and 4 500 delegates due to arrive from 70 countries. Journalists should register now for this top notch event.”

Late breaking trials promise to be the scientific highlight for the press. In three sessions, breakthroughs in clinical heart failure research will be presented from international trials, meta-analyses and registries including:

•    STOP-HF
•    TASTE-IPD collaboration

During four days and 100 scientific sessions international experts will present the latest news on heart failure under the theme “Heart Failure taking centre stage: Drugs, devices and multidisciplinary care”.

Professor Ruschitzka said: “Heart failure is on the move and there are new therapies on the way. Reporters will hear novel trial results in drugs and devices that hold promise to change the treatment landscape. Advances in ventricular assist devices will be discussed along with developments in cardiac resynchronisation therapy and novel valvular interventions to improve outcomes in our heart failure patients. Updates from recently published trials in chronic heart failure will be given, particularly in heart failure with preserved ejection fraction.”

He added: “We will dig into potential mechanisms for the drug LCZ696 which showed huge benefit on top of standard therapy in the PARADIGM-HF trial. Journalists will also gather fresh results from further analysis of the trial data.”

The second World Congress on Acute Heart Failure is part of the main programme again this year. This is the place for the media to get up to speed on current controversies, take a glimpse at therapies on the horizon and hear up to the minute trial results in acute heart failure.

Two honorary lectures will be launched this year. Cardiology legend Professor Eugene Braunwald will give the inaugural Eugene Braunwald lecture and Professor Henry Dargie will present the first Philip Poole-Wilson lecture.

Another first this year is HF – Insuficiencia Cardiaca 2015, a joint venture with the Spanish Heart Failure and Heart Transplant Working Group of the Spanish Society of Cardiology, aimed at local and international Spanish speakers working in heart failure. Four sessions are planned in Spanish, and the track is completed with four sessions in English organised with international partners, the Argentine Society of Cardiology and the Brazilian Society of Cardiology

Dr José Ramón González Juanatey, president of the Spanish Society of Cardiology, will give a lecture on the difficult topic of anticoagulation issues in atrial fibrillation and heart failure.1

Heart Failure 2015 is the premier international forum for professionals interested in heart failure including cardiologists, emergency room physicians, intensivists, internists, cardiac nurses, general physicians, basic scientists and epidemiologists.

Professor Ruschitzka said: “This year’s congress looks set to be the best ever and reporters should save the date to ensure they don’t miss out.”



1Dr José Ramón González Juanatey will give the lecture “Atrial fibrillation and heart failure. Anticoagulation issues” on 24 May during the session “Comorbidities and difficult decisions in heart failure”

Notes to editor

About the Heart Failure Association

The European Society of Cardiology (ESC) represents more than 80 000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.

The Heart Failure Association (HFA) is a registered branch of the ESC. Its aim is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.

Information for journalists attending Heart Failure 2015
Heart Failure 2015 will be held 23 to 26 May in Seville, Spain, at the Sevilla Palacio de Congresos. The full scientific programme is available here

•    Free registration applies to press representatives upon receipt of valid credentials and a fully completed embargo form (to be sent to
•    Credentials: either your ID press card or letter of assignment with proof of three recently published articles that are cardiology related or in another medical field
•    The ESC Press Office will check your credentials and confirm your press accreditation by email.
•    Press registration is not available to Industry or its Public Relations representatives, event management, marketing or communications representatives
•    The decision of the ESC Press Office is final regarding all press registration requests.
•    The ESC Press Office will verify the documents and confirm by email that your Press Accreditation is valid.